MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Utility of Eye Movement Abnormalities in Differentiating Neurodegenerative versus non-Neurodegenerative Parkinsonism

A. Margolius, D. Hengartner, O. Hogue, X. Garcia, S. Patel, A. Ahmed, H. Fernandez, XX. Yu (Bogota, Colombia)

Meeting: 2019 International Congress

Abstract Number: 972

Keywords: Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: To evaluate eye movement abnormalities in patients with neurodegenerative versus non-neurodegenerative parkinsonism.

Background: Clinical distinction between neurodegenerative and non-neurodegenerative parkinsonism can be difficult[1]. Eye movement abnormalities are frequent in patients with Parkinson disease[2]. However, it is unclear if eye movement abnormalities on physical examination are clinically useful in distinguishing neurodegenerative versus non-neurodegenerative causes of parkinsonism.

Method: This is a prospective, single-center, rater-blinded, case control study. Patients with neurodegenerative parkinsonism having at least grade 2 dopaminergic loss on Dopamine Transporter (DaT) scan and patients with non-neurodegenerative parkinsonism confirmed clinically by a movement disorder specialist and by a normal DaT scan were recruited at Cleveland Clinic. Eye movement examination was recorded and shown to two blinded movement disorder specialists to assess pursuit, saccades, presence of gaze limitation, nystagus, and square-wave jerks. Rater-agreed observations were included in further analyses. Sensitivity, specificity, positive predictive value, negative predictive value, and total accuracy were calculated for the presence of each eye movement abnormality against the DaTscan as the gold standard diagnostic tool.

Results: 99 subjects were included in the study, 50 of whom had abnormal DaT scan. Among subjects where there was inter-rater agreement, the prevalence of pursuit abnormalities and saccadic abnormalities was 43.7% and 46.4%, respectively. The interrater agreement was found to be moderate for pursuit abnormalities (κ=0.45, 71 subjects), and slight to moderate for saccadic abnormalities (κ=0.40, 69 subjects). For pursuit abnormalities, sensitivity for detecting neurodegenerative parkinsonism was 47.1% and specificity was 59.5%. For saccadic abnormalities, sensitivity was 51.4% and specificity was 58.8%. Nystagmus, square wave jerks, and gaze limitation all had relatively low prevalence in our study population.

Conclusion: Abnormalities in pursuit and saccades are likely not useful in distinguishing neurodegenerative versus non-neurodegenerative parkinsonism. The prevalence of nystagmus, square wave jerks, and gaze limitation was too low in our study population to draw any conclusions regarding these clinical signs.

References: [1] C. Scherfler, J. Schwarz, A. Antonini, D. Grosset, F. Valldeoriola, K. Marek, W. Oertel, E. Tolosa, A.J. Lees, W. Poewe, Role of DAT-SPECT in the diagnostic work up of Parkinsonism, Mov. Disord. (2007) 1229–1238. doi:10.1002/mds.21505. [2] E.H. Pinkhardt, J. Kassubek, Ocular motor abnormalities in Parkinsonian syndromes, Park. Relat. Disord. (2011) 223–230. doi:10.1016/j.parkreldis.2010.08.004.

To cite this abstract in AMA style:

A. Margolius, D. Hengartner, O. Hogue, X. Garcia, S. Patel, A. Ahmed, H. Fernandez, XX. Yu. Utility of Eye Movement Abnormalities in Differentiating Neurodegenerative versus non-Neurodegenerative Parkinsonism [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/utility-of-eye-movement-abnormalities-in-differentiating-neurodegenerative-versus-non-neurodegenerative-parkinsonism/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/utility-of-eye-movement-abnormalities-in-differentiating-neurodegenerative-versus-non-neurodegenerative-parkinsonism/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley